Eusol Biotech Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Eusol Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury (NCT03229031) | Eusol Biotech Co., Ltd. | 2018-03-07 |
Track Eusol Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.